Henrik Schmidt
8PUBLICATIONS
24CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Oct 19, 2025
Dabrafenib plus trametinib vs encorafenib plus binimetinib in BRAF-mutant metastatic melanoma: a real-world propensity score-matched survival analysis.Yago Garitaonaindia, Shawez Khan, Rasmus Friis
|Apr 14, 2025
Cardiotoxicity in patients with metastatic melanoma treated with BRAF/MEK inhibitors: a real-world analysis of incidence, risk factors, and reversibility.Jonas K Oddershede, Ida K Meklenborg, Lars Bastholt
|Feb 10, 2025
Risk of and Mortality After Acute Kidney Injury Following Cancer Treatment: A Cohort Study.Philip Vestergaard Munch, Mette Nørgaard, Simon Kok Jensen
|Jul 27, 2024
Efficacy of Ipilimumab and Nivolumab in Patients with Melanoma and Brain Metastases-A Danish Real-World Cohort.Karoline Dreyer Kattenhøj, Christine Louise Møberg, Louise Mahncke Guldbrandt
|Nov 13, 2021
Comparison of Efficacy in Patients with Metastatic Melanoma Treated with Ipilimumab and Nivolumab Who Did or Did Not Discontinue Treatment Due to Immune-Related Adverse Events: A Real-World Data Study.Morten Fink, Anders Schwartz Vittrup, Lars Bastholt
|Aug 17, 2021
Effect of patient-reported outcomes as a dialogue-based tool in cancer consultations on patient self-management and health-related quality of life: a clinical, controlled trial.Pernille Christiansen Skovlund, Henriette Vind Thaysen, Henrik Schmidt
Pageof 2
Frequent Collaborators
3 joint publications
Lars Bastholt
3 joint publications
Rasmus Friis
3 joint publications
Eva Ellebaek
3 joint publications
Inge Marie Svane
3 joint publications
Marco Donia
3 joint publications
Christina Ruhlmann
1 joint publications
Anne Vest Soerensen
1 joint publications
Christina Jensen
1 joint publications
Troels H Borch
1 joint publications
Jan Alsner
